A retrospective cohort study of the effectiveness and adverse events of intralesional pentavalent antimonials in the treatment of cutaneous leishmaniasis

A retrospective cohort study of the effectiveness and adverse events of intralesional pentavalent antimonials in the treatment of cutaneous leishmaniasis

Introduction: The standard therapy for American cutaneous leishmaniasis (ACL) is intravenous meglumine antimoniate (IV-MA). However, treatment interruptions due to adverse events (AEs) and non-adherence are frequent. Consequently, intralesional MA (IL-MA) was proposed. Objective: This study examined...

Full description

Bibliographic Details
Main Authors: Bruna Côrtes Rodrigues, Marina Freitas Ferreira, Daniel Holanda Barroso, Jorgeth Oliveira Carneiro da Motta, Carmen Déa Ribeiro de Paula, Cláudia Porto, Sofia Sales Martins, Ciro Martins Gomes, Raimunda Nonata Ribeiro Sampaio
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:International Journal for Parasitology: Drugs and Drug Resistance
Subjects:
Cutaneous leishmaniasis
New world leishmaniasis
Intralesional therapy
Intralesional antimonial
N-methyl glucamine
Pentavalent antimonial
Online Access:http://www.sciencedirect.com/science/article/pii/S2211320720300440

Internet

http://www.sciencedirect.com/science/article/pii/S2211320720300440

Similar Items